Bank of America’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69M | Buy |
730,728
+93,886
| +15% | +$217K | ﹤0.01% | 4123 |
|
|
2025
Q1 | $885K | Sell |
636,842
-1,073,461
| -63% | -$1.49M | ﹤0.01% | 4427 |
|
|
2024
Q4 | $2.96M | Buy |
1,710,303
+1,576,568
| +1,179% | +$2.73M | ﹤0.01% | 3460 |
|
|
2024
Q3 | $269K | Buy |
133,735
+9,761
| +8% | +$19.6K | ﹤0.01% | 5024 |
|
|
2024
Q2 | $278K | Sell |
123,974
-1,739
| -1% | -$3.9K | ﹤0.01% | 4919 |
|
|
2024
Q1 | $361K | Buy |
125,713
+3,385
| +3% | +$9.72K | ﹤0.01% | 4733 |
|
|
2023
Q4 | $217K | Buy |
122,328
+84,148
| +220% | +$149K | ﹤0.01% | 5127 |
|
|
2023
Q3 | $121K | Buy |
38,180
+8,749
| +30% | +$27.6K | ﹤0.01% | 5293 |
|
|
2023
Q2 | $19.5K | Sell |
29,431
-107,570
| -79% | -$71.1K | ﹤0.01% | 5840 |
|
|
2023
Q1 | $109K | Buy |
137,001
+86,625
| +172% | +$69K | ﹤0.01% | 5430 |
|
|
2022
Q4 | $114K | Sell |
50,376
-19,129
| -28% | -$43.2K | ﹤0.01% | 5430 |
|
|
2022
Q3 | $134K | Buy |
69,505
+3,462
| +5% | +$6.67K | ﹤0.01% | 5392 |
|
|
2022
Q2 | $246K | Sell |
66,043
-5,315
| -7% | -$19.8K | ﹤0.01% | 5199 |
|
|
2022
Q1 | $465K | Buy |
71,358
+9,712
| +16% | +$63.3K | ﹤0.01% | 5180 |
|
|
2021
Q4 | $718K | Buy |
61,646
+28,969
| +89% | +$337K | ﹤0.01% | 4841 |
|
|
2021
Q3 | $608K | Buy |
32,677
+8,298
| +34% | +$154K | ﹤0.01% | 4716 |
|
|
2021
Q2 | $517K | Buy |
24,379
+9,524
| +64% | +$202K | ﹤0.01% | 4686 |
|
|
2021
Q1 | $301K | Buy |
14,855
+8,299
| +127% | +$168K | ﹤0.01% | 5102 |
|
|
2020
Q4 | $174K | Buy |
+6,556
| New | +$174K | ﹤0.01% | 4966 |
|